Nuclear Vision Limited (CSE: NUKV) (“Nuclear Vision” or the “Company”) is pleased to announce that it has entered into a ...

High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...

Wharton and Accenture partnered on a huge “skills index” that crunched data on 100 million job postings. They found a “striking and persistent disconnect.” ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

New research raises doubts about claims of microplastics in the human brain, highlighting contamination risks, testing limits, and why results may not be as clear as they seem.

Eldorado Gold reached $434.7M in Q3 revenue as Skouries targets Q1 2026 copper output to de-risk its growth pipeline. Find out why EGO stock is a buy.

The medical electrodes market is expanding on the back of rising diagnostic volumes, aging populations, and higher prevalence ...

This article describes the efficient development of robust analytical methods based on Analytical Quality by Design (AQbD) using dedicated LabSolutions MD software, which supports each phase of the ...

In a period marked by data proliferation, market complexity and regulatory scrutiny, the ability to deliver accurate, timely and actionable information has become central to how financial institutions ...

Nuclear Vision Limited (CSE: NUKV) ("Nuclear Vision" or the "Company") is pleased to announce that it has entered into a definitive ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.